Heparin Sodium
Product Images NDC 0069-0137

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 0069-0137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Heparin 01)

FDA Label Image

Logo (Heparin 02)

This is a description of injectable drugs distributed by Pizer Labs, which is a division of Pfizer Inc located in New York, NY 10017.*

FDA Label Image

Principal Display Panel (10,000 USP units/10 mL Multidose Vial Label)

This is a medication that can be administered subcutaneously or intravenously, derived from Hepa"n, containing 10,000 usp uris/ Distributed by Pfizer Labs in a 10 mL vial with 1,000 usP wnits/mL concentration. It contains Benzyl Alcohol and is not suitable for Lock Flush purposes.*

FDA Label Image

Principal Display Panel (10,000 USP units/10 mL Multidose Vial Carton)

This appears to be a description for a package of Heparin Sodium Injection, USP. It contains twenty-five 10 mL vials, each of which contains 10,000 USP units of heparin sodium. The warning mentions the presence of benzyl alcohol, which may indicate the intended use for subcutaneous or intravenous injection. The rest of the text is illegible or nonsensical.*

FDA Label Image

Principal Display Panel (50,000 USP units/10 mL Multidose Vial Label)

This is a description of Heparin Sodium Injection, USP that is derived from porcine intestinal tissue and distributed by Pfizer Labs in New York City. It is not suitable for Lock Flush and can be administered subcutaneously or intravenously. It comes in a Multi-dose Vial and contains 5,000 US units/mlL of Heparin Sodium Injection, USP. Users are advised that it is for Rx use only and contains Benzyl Alcohol which could be harmful.*

FDA Label Image

Principal Display Panel (50,000 USP units/10 mL Multidose Vial Carton)

The text appears to be a product label for Heparin Sodium Injection, USP. It contains information about the concentration of the injection, its intended use, and dosage instructions. It also provides warnings about the use of the injection and storage recommendations. However, some parts of the text are not readable, making it difficult to provide a complete description.*

FDA Label Image

Principal Display Panel (1 mL Multidose Vial Label Multidose Vial Label)

This is a description of Heparin Sodium Injection, USP, a medication used for subcutaneous or intravenous use that is derived from porcine intestinal tissue. The medication is distributed by Pizer Labs, a division of Pfizer Inc in NY, NY 10017. This medication is not to be used for lock flush and comes in a multidose vial. Each mL of the medication contains 10,000 USP units of Heparin Sodium Injection, USP. It is important to note that this medication contains Benzyl Alcohol and is only available with a prescription.*

FDA Label Image

Principal Display Panel (1 mL Multidose Vial Carton)

This is a description for Heparin Sodium Injection, USP, which contains 10,000 USP units/mL and is derived from porcine. This medication can be used for subcutaneous or intravenous use. There is a warning about the presence of Benzyl Alcohol in the medication. The dosage of the medication depends on the accompanying information.*

FDA Label Image

Principal Display Panel (2 mL Single Dose Vial Label)

This is a product description for Pfizer Labs' Heparin Sodium Injection. It is meant for either subcutaneous or intravenous use and contains 2,000 USP units per 2 mL or 1,000 USP units per mL. The injection requires a prescription and comes in a single-dose vial. It is comprised of porcine intestinal tissue and distributed by Pfizer Labs. The NDC number is 0069-0043-02. The injection does not contain a preservative and unused portions should be discarded. It is not intended for Lock.*

FDA Label Image

Principal Display Panel (2 mL Single Dose Vial Carton)

This appears to be a product label for Heparin Sodium Injection, USP containing 2,000 usp units/2 mL (1,000 usp units per mL). The medication is intended for subcutaneous or intravenous administration. The label also mentions the storage instructions and dosage recommendations.*

FDA Label Image

Principal Display Panel (30 mL Multidose Vial Label)

HEPARIN Sodium Injection is a prescription medication derived from porcine intestinal tissue, that is used for subcutaneous or intravenous administration. This injectable liquid comes in multidose vials containing 30,000 units of USP heparin sodium in 30mL of the liquid with 1,000 units of USP per milliliter. This medication is distributed by Pfizer Labs under the division of Pfizer Inc in New York, NY, USA. However, despite its use for flushing catheters, it is not recommended for lock flushing. HEPARIN Sodium contains benzyl alcohol and should be prescribed only by a healthcare professional.*

FDA Label Image

Principal Display Panel (30 mL Vial Carton)

This is a description of HEPARIN Sodium Injection, USP, which is provided in Ten- 30 mL Multidose Vials. The solution is derived from porcine intestinal tissue and contains 30,000 usp Units of Heparin Sodium in each 30 mL vial (with 1,000 USP Units per mL). The solution can be used for subcutaneous or intravenous use. Each mL of the solution contains 1,000 USP units of Heparin. The solution contains Benzyl Alcohol and should not be used for Lock Flush. The product is provided with accompanying prescribing information. The vials should be stored at controlled room temperature (20° 0 25°C or 68° 0 77°F as per USP).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.